Skip to main content
logo
Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
51.05
-0.55 (-1.07%)
Jul 30, 2026, 3:39 PM HKT

Nanjing Leads Biolabs Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Revenue
177.26177.26-8.87
Revenue Growth
----
Gross Profit
177.26177.26-5.68
Operating Income
-194.53-194.53-273.38-263.23
Net Income
-211.42-211.42-301.22-362.25
Earnings Per Share
-1.21-1.21-2.01-2.50
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
1,5481,548538.72347.65
Total Debt
280.56280.56266.4867.09
Net Cash (Debt)
1,2671,267272.24280.57
Net Cash Growth
365.57%365.57%-2.97%-
Net Cash Per Share
7.287.281.811.94

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-154.43-154.43-118.82-192.69
Capital Expenditures
-8.23-8.23-2.98-11.73
Free Cash Flow
-162.65-162.65-121.79-204.41
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Gross Margin
100.00%100.00%-64.07%
Operating Margin
-109.75%-109.75%--2969.26%
Pretax Margin
-110.51%-110.51%--4086.28%
Profit Margin
-119.27%-119.27%--4086.28%
FCF Margin
-91.76%-91.76%--2305.84%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingJul '26 Dec '25 Dec '24 Dec '23
PS Ratio
52.0351.42--